Latest Period
Q2 2026
Security Snapshot
Drugs Made In America Acquisition II Corp. - RIGHT 09/16/2030 (DMIIR) Institutional Ownership
CUSIP: G2851K112
13F Institutional Holders and Ownership History from Q4 2025 to Q2 2026
Institutions Reporting
59
Shares (Excl. Options)
40,494,304
Price
$0.08
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / RIGHT 09/16/2030
- Symbol
- DMIIR on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 40,494,304
- Total 13F value
- $3,204,532
- Portfolio coverage rank
- 0%
- Share change
- +917,947
- Value change
- +$76,035
- Number of holders
- 59
- SEC-reported price per share
- $0.08
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
1 identity field
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- DMIIR - Drugs Made In America Acquisition II Corp. - RIGHT 09/16/2030 is tracked under CUSIP G2851K112.
- 59 institutions reported positions in Q2 2026.
- Schedule 13D/13G significant owner rows are not currently available.
Change
- Holder count moved from 56 to 59 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $3,189,426 to $3,204,532.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 59 institutions filings for Q2 2026.
Security key
G2851K112
Latest holder period
Q2 2026
13F holders
59
13D/G owners
0
CIK / CUSIP context first
Open Q2 2026 holders
DMIIR full holder history
Drugs Made In America Acquisition II Corp. SEC filings
Drugs Made In America Acquisition II Corp. company facts
Drugs Made In America Acquisition II Corp. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP G2851K112:
As of 30 Jun 2026, 59 institutional investors reported holding 40,494,304 shares of Drugs Made In America Acquisition II Corp. - RIGHT 09/16/2030 (DMIIR).
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
3
Latest
Q2 2026
Rows shown
1-3 of 3